Calcium gluconate injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.
From the U.S. FDA-approved label for Calcium gluconate. Full label: DailyMed.
Calcium gluconate injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.
From the U.S. FDA-approved label for Calcium gluconate. Full label: DailyMed.
Contains 100 mg of calcium gluconate per mL which contains 9.3 mg (0.465 mEq) of elemental calcium. Administer intravenously (bolus or continuous infusion) via a secure intravenous line. See Full Prescribing Information (FPI) for dilution instructions, administration rates and appropriate monitoring.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Calcium gluconate injection is contraindicated in: Hypercalcemia. Neonates (28 days of age or younger) receiving ceftriaxone. Neonates (28 days of age or younger) receiving ceftriaxone.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Arrhythmias with Concomitant Cardiac Glycoside Use: If concomitant therapy is necessary, calcium gluconate injection should be given slowly in small amounts and close ECG monitoring is recommended. End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates: Concurrent use of intravenous ceftriaxone may cause life-threatening precipitates. Cases of fatal outcomes in neonates have occurred. Tissue Necrosis and Calcinosis: Calcinosis cutis can occur with or without extravasation of calcium gluconate injection. Tissue necrosis, ulceration and secondary infection are the most serious complications.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are also described elsewhere in the labeling: Arrhythmias with Concomitant Cardiac Glycoside Use End-Organ Damage due to Intravascular Ceftriaxone-Calcium Precipitates Tissue Necrosis and Calcinosis Hypotension, Bradycardia and Cardiac Arrhythmias Aluminum toxicity The following adverse reactions associated with the use of calcium gluconate were identified in the literature.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
5 products from 4 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Calcium 10ml Injection | Calcium Gluconate (10ml) | Hindusthan Pharmaceuticals Ltd. | |
| Calcium 250mg Tablet | Calcium Gluconate (250mg) | Novartis India Ltd. | |
| Calcium 500mg Tablet | Calcium Gluconate (500mg) | Novartis India Ltd. | |
| Cgglu 500 Tablet | Calcium Gluconate (500mg) | Cmg Biotech Pvt Ltd | strip of 10 tablets |
| Glumig Injection | Calcium Gluconate (10mg) | RSM Kilitch Pharma Pvt Ltd | vial of 10 ml Injection |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
